Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. - Wikidata - awgldk - TriplyDB

Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial.

Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial.

http://www.wikidata.org/entity/Q51434527

about

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:Timely and optimal treatment of patients with STEMI Factors associated with presenting >12 hours after symptom onset of acute myocardial infarction among Veteran men.Remote ischemic conditioning.Impact of multivessel coronary disease with chronic total occlusion on one-year mortality in patients with acute myocardial infarction.Myocardial infarction in the elderly Clinical Characteristics and Outcomes of Acute ST-Segment Elevation Myocardial Infarction in Younger Korean Adults.ST segment elevation differs depending on the method of measurement.Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial Outcome selection and role of patient reported outcomes in contemporary cardiovascular trials: systematic review.2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi Treatment of Myocardial Ischemia/Reperfusion Injury by Ischemic and Pharmacological Postconditioning.Myocardial salvage after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction presenting early versus late after symptom onset.Remote ischaemic conditioning and remodelling following myocardial infarction: current evidence and future perspectives.The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.Remote Ischemic Conditioning for Patients With STEMI.[Evidence-based management of ST-segment elevation myocardial infarction (STEMI). Latest guidelines of the European Society of Cardiology (ESC) 2010].Puerarin accelerate scardiac angiogenesis and improves cardiac function of myocardial infarction by upregulating VEGFA, Ang-1 and Ang-2 in rats.Prognostic value of late gadolinium enhancement in cardiovascular magnetic resonance imaging after acute ST-elevation myocardial infarction in comparison with single-photon emission tomography using Tc99m-Sestamibi.Patients with ST-segment elevation of myocardial infarction miss out on early reperfusion: when to undergo delayed revascularization.Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h.Improvements in Regional Left Ventricular Function Following Late Percutaneous Coronary Intervention for Anterior Myocardial Infarction.Late percutaneous coronary intervention prevents left ventricular remodeling and improves clinical outcomes in patients with ST-elevation myocardial infarction.Quality indicators for acute myocardial infarction: A position paper of the Acute Cardiovascular Care Association.Cardiological Society of India: Position statement for the management of ST elevation myocardial infarction in India.Estimate of myocardial salvage in late presentation acute myocardial infarction by comparing functional and perfusion abnormalities in predischarge gated SPECT.Expert Consensus Document on Management of ST-Elevation Myocardial Infarction: Adaptation of 2012 ESC Guidelines.Early treatment with abciximab in patients with ST elevation myocardial infarction results in a high rate of normal or near normal blood flow in the infarct related artery

P2860

Q22242896-909F3041-8FFA-4928-A102-9E2FF522D5D6 Q22251044-C1E544D8-94CB-47BD-A991-B7181367C7A8 Q34424159-F21E5A74-97F6-46B9-A4DE-486DA07B32D0 Q34458416-91DF4433-E893-4200-B2FD-E1E3C2C5682C Q35794823-ABF43413-E075-4E32-B24B-C1D1C8D2F4D9 Q35806730-ED350750-00E1-4CEA-8CA0-9715BB99F0FB Q35905568-80E123BB-0D79-474D-B1C4-4B7949629FB0 Q36419098-4A8CA68F-2395-49D3-9DAC-C4FFAA861B64 Q37090548-DC9A27E7-8525-48B4-81F7-DF571024DE02 Q37805903-CD85AF8A-B778-4EA0-AD16-50CE85254371 Q37953885-6A195B14-5EE8-487B-AE5E-BD5A13345CAB Q38542449-36BBD22A-4BF9-4F53-A0A1-3E5433922E58 Q38821683-5DE3F1E5-980D-4744-9E2A-FF485116612A Q38833919-5B412279-D4A8-457D-9D01-2E85F8505F59 Q38880162-95AA1344-E8EA-45A8-84E2-FDF8BC3151E2 Q39222527-8F05264D-03BD-4A23-9A53-29D956ABADF7 Q42792435-F27C81EC-CE7A-41F4-A786-4457B9BFB3E4 Q43072504-C07D5FF8-6C04-4899-958C-E676EBB220D5 Q43801285-D7ACAF96-3246-4399-B21D-9AD953247920 Q47155137-9DCC3B7E-1DC4-43FD-A67E-79083855A495 Q47188739-0DC19F8A-FC07-430E-AA33-70BCB17B5624 Q47195807-A33B5D2A-717F-4FDD-B48E-23A5CFBD184C Q51011773-3577C206-47EA-42AF-80A2-513683959A9E Q52814619-9FF6DE1A-3241-4AE2-8EF4-E3CDC7DDEF92 Q53363030-42FDEA3C-83C9-4063-922E-56FBB033C703 Q53447626-60DD2468-26C4-445F-9207-4E3DEE65EBE6 Q55009897-3B9BE4FD-A506-42DA-B550-3117F350DACB Q58088726-2013A1D7-C33B-47DF-913C-F19E4404236D

P2860

Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial.

http://www.wikidata.org/entity/Q51434527

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Mechanical reperfusion in pati ...... a randomized controlled trial.

@en

Mechanical reperfusion in pati ...... a randomized controlled trial.

@nl

type

label

Mechanical reperfusion in pati ...... a randomized controlled trial.

@en

Mechanical reperfusion in pati ...... a randomized controlled trial.

@nl

prefLabel

Mechanical reperfusion in pati ...... a randomized controlled trial.

@en

Mechanical reperfusion in pati ...... a randomized controlled trial.

@nl

P1433

Q51434527-FA6DA2C7-5730-479B-9F37-A9A7CD850AE7

P1476

Q51434527-9ADF0845-5F23-4686-ADC5-A1110C13E281

P2093

Q51434527-0ADCF3DB-851B-48FB-8F90-6661B9C17B25

Q51434527-24CF46F1-6F9A-4A41-AA3B-76C6122D0EF9

Q51434527-2585C160-EF2B-4CE9-B365-09D04FB4A857

Q51434527-4A3CC3FD-8B06-43CC-8AE5-E89217252D43

Q51434527-4A79CD94-38E0-4B36-A461-5F84644B1A69

Q51434527-720ED23D-5079-4742-994A-68591EFC8F95

Q51434527-7C8E072C-7EC3-4D8D-94D6-E9BE27E60F1E

Q51434527-A541039A-C82B-4E3D-A576-BF399827EFB0

Q51434527-ABA622DD-448D-44B0-B82E-53B1DE0985AC

Q51434527-ABEA441E-B981-4B7F-A8CF-A560EDE9B59C

P304

Q51434527-969EF2BF-2047-4808-AF04-D25B4AAE886A

P31

Q51434527-4F76299D-439B-48FD-B6B6-1F73E2D114F0

P356

Q51434527-801A653A-819D-491C-8D92-7C2EDBAC4AEB

P407

Q51434527-88B4115F-A29A-48D0-8587-7AF26F3C123C

P433

Q51434527-6930F46B-6538-4107-8154-D0D5A0B460E3

P478

Q51434527-868E4A1A-8E6D-4946-930E-8F78990FFED6

P50

Q51434527-11E31AA5-A43F-4791-B46E-85ED073FFC3D

Q51434527-446E9AC5-15E6-4430-A1E1-946C67846BF7

Q51434527-72B4CEF1-7AB6-4187-9AB2-137191E3BEFE

Q51434527-A7AF92D0-10B9-4554-A81F-11F84FE1D922

Q51434527-D49A3455-66E8-47FD-96DB-6D2A627A288F

P577

Q51434527-D465F01F-A20B-4585-BEE8-7DFE30502858

P5875

Q51434527-C79851B0-889E-4032-8344-1778AB61DE6A

P698

Q51434527-1558E8FB-E277-48FC-9E50-AC685DFE3720

P921

Q51434527-14B3A7FC-8B56-410B-BEBA-8690DCDD0C67

P356

JAMA.293.23.2865

P1433

Journal of the American Medical Association

P1476

Mechanical reperfusion in pati ...... a randomized controlled trial.

@en

P2093

Beyond 12 hours Reperfusion AlternatiVe Evaluation (BRAVE-2) Trial Investigators

http://www.w3.org/2001/XMLSchema#string

Christina Markwardt

http://www.w3.org/2001/XMLSchema#string

Claus Schmitt

http://www.w3.org/2001/XMLSchema#string

David Antoniucci

http://www.w3.org/2001/XMLSchema#string

Francesco Di Pede

http://www.w3.org/2001/XMLSchema#string

Gjin Ndrepepa

http://www.w3.org/2001/XMLSchema#string

Helmut Schühlen

http://www.w3.org/2001/XMLSchema#string

Josef Dirschinger

http://www.w3.org/2001/XMLSchema#string

Jürgen Pache

http://www.w3.org/2001/XMLSchema#string

Klaus Schlotterbeck

http://www.w3.org/2001/XMLSchema#string

P304

2865-2872

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.293.23.2865

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

293

http://www.w3.org/2001/XMLSchema#string

P50

Julinda Mehilli

Stephan G Nekolla

Markus Schwaiger

Albert Schömig

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7785481

http://www.w3.org/2001/XMLSchema#string

P698

15956631

http://www.w3.org/2001/XMLSchema#string

P921